Sign in
4

Changes in Ownership

NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001709738-25-000006

Business Development Director sold 8,981 shares at an average $0.62 ($5,596)

From the SEC's structured data for this filing

Trades in this filing

Christianson Mark · Business Development Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-05-21 Sale : show line 1 in the form −14 $0.65 $9 280,458 D
2025-05-22 Sale : show line 2 in the form −8,967 $0.62 $5,586 271,491 D
Open-market sales · 8,981 sh · avg $0.62 · $5,596
Loading xslF345X05/primary_doc.xml…